STOCK TITAN

Karyopharm Therapeutics (KPTI) affiliated managers report 1.9%–2.3% stakes

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Karyopharm Therapeutics Inc. ownership update: three affiliated Millennium entities and Israel A. Englander report shared beneficial interests in common stock as of 03/31/2026. Integrated Core Strategies (US) LLC reports 423,982 shares (1.9%); Millennium Management LLC, Millennium Group Management LLC and Mr. Englander each report 511,571 shares (2.3%). The filing states these holdings are subject to shared voting and dispositive power and includes a joint filing agreement dated April 10, 2026.

Positive

  • None.

Negative

  • None.

Insights

Routine ownership disclosure by affiliated investment managers and principal.

The Schedule 13G/A lists shared voting and dispositive power for listed Millennium entities and Israel A. Englander over specified share amounts: 423,982 shares and 511,571 shares, with reported percentages of 1.9% and 2.3% respectively as of 03/31/2026. The filing reflects joint reporting rather than a change-of-control assertion.

Cash‑flow treatment and intent (passive vs active investment) are not stated; the joint filing agreement dated April 10, 2026 governs coordinated disclosure. Subsequent filings would show material changes to these positions.

Reporting date 03/31/2026 cover page reporting date
Integrated Core Strategies (US) LLC holdings 423,982 shares reported shared voting/dispositive power, <date>03/31/2026</date>
Millennium / Englander holdings 511,571 shares each reported with shared voting/dispositive power, <date>03/31/2026</date>
Reported ownership percentages 1.9% and 2.3% percent of class shown on cover pages
Schedule 13G/A regulatory
"Amendment No. 1 ) Karyopharm Therapeutics Inc."
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Shared Voting Power financial
"Shared Voting Power 423,982.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Joint Filing Agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of April 10, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Integrated Core Strategies (US) LLC report in KPTI?

Integrated Core Strategies (US) LLC reports 423,982 shares, representing 1.9% of Karyopharm common stock as of 03/31/2026. The filing shows shared voting and dispositive power over these shares.

How many shares do Millennium entities and Israel A. Englander report in KPTI?

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report 511,571 shares, equal to 2.3% of the class as of 03/31/2026. The holdings are reported with shared voting and dispositive power.

What form was filed to report these holdings for KPTI?

A Schedule 13G/A amendment was filed to disclose beneficial ownership for Karyopharm common stock, with reporting parties filing a joint filing agreement dated April 10, 2026.

Does the filing state whether these holders control Karyopharm?

No. The filing explains holdings are subject to voting control and investment discretion by Millennium managers but explicitly notes this should not be construed as an admission of beneficial ownership or control.

What is the reporting date for the KPTI share counts?

The share counts are presented with an effective date of 03/31/2026 on the cover pages, and signatures on the amendment are dated April 10, 2026.





48576U205

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:04/10/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:04/10/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:04/10/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:04/10/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of April 10, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.